Curriculum Vitae John Spertus, md mph facc faha
Yüklə 286,42 Kb.
|
- Bu səhifədəki naviqasiya:
- Spertus, J
- Spertus, J.A
- Spertus JA
- Spertus J
- Invited Presentations and Conferences
Spertus JA, Conard MW, Rinaldi J, Tsuyuki R, Krumholz H, Pina I, Havranek E, Tooley JF. The Kansas City Cardiomyopathy Questionnaire is sensitive to clinical change in congestive heart failure. Journal of the American College of Cardiology 2002;39(5):460A. Garg M, Bliven B, House J, Spertus JA. Gender differences in social support trends following coronary revascularization. Journal of the American College of Cardiology 2002;39(5):455A. Garg M, Bliven B, Jones P, Spertus JA. Low perceived social support influences quality of life of female patients undergoing coronary revascularization. Journal of the American College of Cardiology 2002;39(5):437A. Farner, M, Martinez, O, Bandt, K, Hayden, L, Hannen, M, Riaz, K, Spertus, J: Older Patients undergoing revascularization have better disease-specific quality of life than younger patients despite similar symptom frequency. Am Heart J, 2001. Sullivan, M, Newton, K, Spertus, J, Hecht, J: Depression and Heart Failure: Primary Care Am Heart J, 2001, Am J Geriatr Cardiol. Sullivan, M, Levy, W, Spertus, J, Russo, J: Depression and Heart Failure: Tertiary Care, Am Heart J, 2001. Rumsfeld, J, Magid, D, Plomodon, M, Spertus, J, O’Brien, M, Every, N, Sales, A, Depression Is Associated with Anginal Frequency, Anginal Stability, Physical Limitations, and Quality of Life Following Acute Coronary Syndromes, Am Heart J, 2001.
Borkon, M, Muehlebach, G, Marso, S, Jones, P, Spertus, J: Health Status Recovery after Revascularization: PCI vs CABG, Am Heart J, 2001. Vaglio, J, Conard, M, Poston, C, O’Keefe, J, Spertus, J: Comparing the Impact of Living Alone vs Perceived Social Support on the Health Status of Cardiac Patients, Am Heart J, 2001. Vaglio, J, Conard, M, Poston, C, O’Keefe, J, Spertus, J: Testing the Performance of an Abbreviated Social Support Questionnaire in Cardiac Patients, Am Heart J, 2001. Jones, P, Spertus, J: The Benefit Statistic: A New Method for Analyzing Health Status, Am Heart J, 2001. Riaz, K, Bandt, K, Hayden, L, Farner, M, Martinez, O, McCullough, P, Spertus, J: The Implications of Ordering Troponin in Patients at Low-Risk for ACS, Am Heart J, 2001. Seavey, G, Hayden, L, Johnson, J, Johnson, W, Locke, A, McCallister, B, Spertus, J: The MAHI Admissions and Discharge Forms: An Effort to Integrate the Assessment of Performance Measures throughout the Process of Healthcare, Am Heart J, 2001. Green, D, House, J, Spertus, J: The Relationship Between Angina Frequency and Patients’ Quality of Life, Am Heart J, 2001. Rumsfeld, J.S.; Magid, D.J.; Plomondon, M.E.; Spertus, J.A.; O'Brien, M. M.; Every, N.R.; Sales, A.E. : Depression is associated with anginal frequency, anginal stability, physical limitation and quality of life following acute coronary syndromes. Circulation 2001; 104(17): II-649. Jurkovitz, C.T.; Mahoney, E.; Chu, H.; Alexander, C.; Murrah, N.V.; Nag, S.; Spertus, J.A. Prediction of coronary events in the TACTICS-TIMI 18 Trial: could the SAQ be used? Circulation 2001; 104(17): II-797 Kimble, L.P.; Dunbar, S.B.; Spertus, J.A.; Teo, K.; Veledar, E.; Lewis, C.; Weintraub, W.S. Self-reported difficulty with coronary artery disease management is associated with lower quality of life. Circulation 2001; 104(17): II-373.
Borkon, M.; Spertus, J.A.; Bliven, B.D.; Jones, P.G.; Akhras, K.; Tooley, J. Recovery of physical function after revascularization: temporal patterns following PCI and CABG. Journal of the American College of Cardiology. 2001: 510A Jones PG, Spertus JA, McDonell M, Fan V, Fihn SD: Health status predicts long-term outcome in patients with coronary artery disease. 2001: 37: 491A
Johnston G, Malmgren J, Goss R, Spertus J: Statewide risk modeling for CABG postoperative length of stay and the importance of patient reported health status: Data from the pilot phase of the Washington State Cardiac Outcomes Assessment Program. J Am Coll Cardiol 2001: 37: 491A Garg M, Bliven B, Jones P, Spertus J: Gender differences in disease-specific functional status following CABG. Journal of the American College of Cardiology 2001: 37: 493A Weintraub WS, Spertus JA, Veledar E, Lewis C, Mahoney E, Hartigan PM, Maron DJ, Teo K, Casperson P, Potter K, Dunbar SB, O’Rourke RA, Boden WE,: Improvement in health status at 3 months in the COURAGE trial: Seattle Angina Questionnaire Results. Journal of the American College of Cardiology 2001: 37: 327A Spertus JA, Hanson K, Kaufman SE, Sumner W, Nease R, Dunbar SB, Hartigan PM, O’Rourke RA, Weintraub WS: New frontiers in assessing outcomes for clinical trials”: Implementation of computerized health status/utility assessment in the COURAGE trial. Journal of the American College of Cardiology 2001: 37: 498A Fong PP, Sales AE, Parsons LS, Spertus JA Caldwell DM, Every NR: Functional status in veterans after discharge for unstable angina pectoris vs AMI. Circulation 2000; 102: II-851 Beinart SC, Sales AE, Parsons LS, Spertus JA, Caldwell DM, Every NE: Predictors of treatment satisfaction after admission for AMI and unstable angina. Circulation 2000; 102: II-850 Rumsfeld JS, Magid DJ, O’Brien MM, Plomondon ME, Parsons LS, Spertus JA, Every NE, Sales AE: Predictors of quality of life following acute coronary syndromes. Circulation 2000; 102: II-849 Marso SP, Vacek JL, Bliven BD, Rutherford BD, Spertus JA: Culprit artery angioplasty: Complete revascularization and health status following PCI. Circulation 2000; 102: II-840 Bliven BD, Vacek JL, Poston WSC, Haddock KC, Spertus JA: Association of economic burden and functional status following percutaneous coronary intervention. Circulation 2000; 102: II-840 Garg M, Coen M, Spertus J: Predictors of outcome after transmyocardial revascularization. Journal of the American College of Cardiology 2000: 35: 342
McCullough PA, Philbin EF, Czerka B, Spertus JA, Weaver EWD. Population-based medication profiling in heart failure: Treatment related outcomes from the R.E.A.C.H. study. Journal of the American College of Cardiology 2000: 35: 542A McCullough PA, Philbin EF, Czerka B, Spertus JA, Weaver EWD. The diagnostic evaluation of newly discovered heart failure: Opportunities for improvement from the R.E.A.C.H. study. Journal of the American College of Cardiology 2000: 35: 327A McCullough PA, Philbin EF, Spertus JA, Weaver EWD. Gender differences in the diagnostic evaluation of heart failure: Findings from the R.E.A.C.H. study. American Heart Association Quality of Care and Outcomes Research Conference 2000: P23 Spertus JA, Garg M, Jones P, O’Keefe J. Transmyocardial revascularization improves quality of life: Results of a multicenter clinical trial. Circulation 1999, Fine JT, Bajamande A, McCluskey ER, Henry T, Spertus J. Unexplained improvement in health-related quality of life in the vascular endothelial growth factor in ischemia for vascular angiogenesis trial. Circulation 1999. Every N, Neil N, Cohen D, Spertus J, Ramsey S, Weaver WD. Resource utilization and health status impact of primary stent vs. optimal PTCA: The OPUS Trial. Circulation 1999. Chowdry S, Kramer P, Spertus J, Crouse L. The effect of treadmill exercise on pulmonary artery pressure in normal patients. Circulation 1999. Green CP, Bresnahan D, Porter C, Spertus JA. Development of the Kansas City Cardiomyopathy Questionnaire. J Am Coll Cardiol 1999; 33(2) 247A.
Dougherty CM, Nichol WP, Dewhurst T, Spertus J, Fihn S, McDonell M: Comparison of anginal symptoms over six months in two populations. J Gen Intern Med 1997; 12 (suppl): 69. McLean K, Spertus JA, Tognazzi-Evans T, Jurkovich GJ, Comess KA: Role of echocardiography in the evaluation of blunt or penetrating thoracic trauma. J Am Soc Echo 1997; Kaufman S, Spertus JA: A Java-based world wide web computer system for longitudinal assessment of health outcome measures using the Seattle Angina Questionnaire. J Am Coll Cardiol 1997; 29(2) Supplement A: 9A Spertus, JA. Evaluating the quality of care in cardiovascular disease: A primer on techniques of process and outcomes assessment. American Association of Health Plans’ (AAHP) Building Bridges Conference. Dougherty CM, Spertus J, Dewhurst TA, Nichol WP. Nurse practitioner managed angina clinic improves quality of life. J Am Coll Cardiol 1997; 29(2) Supplement A: 168A. Dewhurst TA, Dougherty CM, Spertus J, Nichol WP. Once daily medications improve quality of life in stable angina: 6-month followup. J Am Coll Cardiol 1997; 29(2) Supplement A: 167A.
Dewhurst TA, Dougherty CM, Ince S, Nichol P, Spertus JA: Improved outcomes in stable angina with once daily medications. Circulation 1996. Kaufman SE, Spertus JA. The WebRes Project: Web-based client-server technologies for multicenter clinical research. In: Gardner RM, ed. Proceedings of the 19th annual symposium on computer applications in medical care, Washington, DC 1995.
2/6/98: Emory University Cardiovascular Epidemiology Conference: The Role of Quality of Life Measures in Outcomes Research, Atlanta, GA 3/31/98: Co-chair, American College of Cardiology, Meet the Experts Session: Practical Quality of Life Testing Atlanta, GA 4/8/98: National Jewish Medical and Research Center and Medical Outcomes Trust Symposium: Exploring Outcomes: A New Directive in Disease Management Denver, CO 4/30/98: Illinois Chapter of the American College of Cardiology: Quality of Life Outcomes in Disease Management and Quality Assessment Chicago, IL 6/6/98: American College of Sports Medicine, Symposium Presenter: Development and Testing of Health-related Quality of Life Instruments for Cardiopulmonary Disease Orlando, FL 7/29/98: University of Iowa Cardiology Grand Rounds: New Applications of Quality of Life Measures: Clinical Trials, Disease Management, and Health Care Quality Iowa City, IA 11/8/98: Scientific Session of the American Heart Association: Quality Care Initiatives in the Treatment of Cardiovascular Disease and Stroke: Who Cares and Why Dallas, TX 5/24/99: Scientific Forum on Cardiovascular Disease and Stroke Quality of Care and Outcomes Research: Challenges in Collecting Outcomes Measures San Diego, CA 5/25/99: Scientific Forum on Cardiovascular Disease and Stroke Quality of Care and Outcomes Research: Quality of Life and Functional Status San Diego, CA 6/12/99: APPROACH Workshop: Interpretation and Use of the Seattle Angina Questionnaire Vancouver, BC Canada 11/2/99: Plenary Session of the Scientific Sessions of the American College of Chest Physicians: Use and Interpretation of Quality of Life Measures Chicago, IL 11/9/99: American Heart Association Scientific Sessions: Abstract Moderator for session on Outcomes of Percutaneous Revascularization Anaheim, CA 11/24/99:Henry Ford Healthcare System Grand Rounds: Quantifying Health Status in Cardiovascular Disease Detroit, MI 1/22/00: Special Advisory Committee on the Treatment of Patients with Advanced Heart Failure: Outcomes Research Techniques for Quantifying the Benefits of Treatment for Patients with Advanced Heart Failure Miami, FL 1/25/00: Duke University Clinical Research Institute: Applications of Health Status in Cardiovascular Disease, Durham, NC 1/28/00: Quantifying Quality of Life: AHA Scientific Conference on Geriatric Cardiology: Do Existing Databases Hold the Answer?, 3/10/00: Truman Medical Center and UMKC Grand Rounds: New Applications of Health Status in Cardiovascular Disease: Clinical Trials, Quality Assessment and Patient Care, Kansas City, MO 3/13/00: Cato Research Investigators’ Meeting: The Role of Health Status as an Endpoint in Clinical Trials of Angiogenesis Orlando, FL 4/3/00: 2nd Annual Conference on Outcomes and Quality of Care. The Phoenix Group: Flagstaff, AZ 4/10/00: Second Scientific Forum on Outcomes Research and Quality of Care in Cardiovascular Disease and Stroke: Defining the Appropriateness of Percutaneous Coronary Interventions, Washington, DC 4/10/00: Second Scientific Forum on Outcomes Research and Quality of Care in Cardiovascular Disease and Stroke: Interpreting Health Status Measures, Washington, DC 8/3/00: University of Kansas Interdisciplinary Research Conference 8/4/00: University of Iowa Course on Patient-centered Outcomes Research: Health Status Assessment – From the Basics to the State of the Art 9/12/00: Heart Failure Society of America Annual Meeting: Is Quality of Life a Surrogate in Clinical Trials – Plenary Session Boca Raton, FL 9/12/00: Heart Failure Society of America Annual Meeting: How to Measure Quality of Life in Patients with Congestive Heart Failure Boca Raton, FL 9/30/00: Mid America Cardiology Update in Cardiology and Cardiovascular Emergencies: The Role of Health Status in Patient Care, Kansas City, MO 10/07/00: 11th Annual Scientific Sessions of the Louisiana Chapter of the American College of Cardiology: The Role of Health Status in Patient Care New Orleans, LA 11/17/00: Plenary Speaker, National Armed Forces Meeting of the American College of Physicians: Applications of Health Status in Patient Care and the Assessment of Healthcare Quality Washington, DC 3/17/01: ACC NCDR User’s Group Meeting Keynote Speaker: Uses of Cardiovascular Databases to Improve the Quality of Cardiovascular Care Orlando, FL 3/21/01: American College of Cardiology Abstract Session Moderator: Heart Failure Outcomes and How to Prevent Them Orlando, FL 4/11/01: Yale University Cardiovascular Research Conference: Health Status Assessment in Cardiovascular Disease: Transitioning from Research to Patient Care, New Haven, CT 4/26/01: Missouri Institute for Quality Care: Leveraging Data to Improve the Quality of Patient Care Jefferson City, MO 6/4/01: Visiting Professor, Cornell University including CV Grand Rounds on The Evolution of Outcomes Research in Cardiology New York, NY 6/18/01: AstraZeneca Pharmaceuticals: Health Status as a Primary Endpoint in Clinical Trials – Methodological Rationale and Implications Philadelphia, PA 10/1/01: 3rd Annual Scientific Forum on Quality of Care and Outcomes Research: Creating and Using a Database for Quality Improvement, Washington, DC 11/10/01: Pre-AHA Symposium by CV Therapeutics: Angina, the Unmet Need Anaheim, CA 11/12/01: AHA Scientific Sessions Abstract Moderator: Quality of Life for patients with Heart Disease Anaheim, CA 11/13/01: AHA Scientific Sessions Meet the Experts Session: How to Measure and Interpret Quality of Life in Heart Failure Anaheim, CA 11/27/01: Kansas City Area Life Sciences Research Day: Overview of Outcomes Research and Activities at the Mid America Heart Institute, Kansas City, MO 1/19/01: CV Therapeutics Ranolazine Advisory Board: Chronic Angina: The Unmet Need for New Therapeutic and Healthcare System Strategies Cleveland OH 1/24/02: Cardiovascular Grand Rounds, Mid America Heart Institute: New Paradigms for Selecting the Mode of Coronary Revascularization, Kansas City, MO 3/16/02: ACC NCDR User’s Group Meeting Keynote Speaker: Creating a Database for Quality Improvement Atlanta, GA 3/19/02: ACC Scientific Sessions Abstract Moderator: Quality of Care in Arrhythmias, Atlanta, GA 4/04/02: Dartmouth Center for Evaluative Clinical Studies Grand Rounds: Transitioning Outcomes Research into Practice: The Evolution of Patient-centered Assessments, Hanover, NH 4/18/02: Case Western’s Cardiovascular Grand Rounds: Transitioning Outcomes Research into Practice: The Evolution of Patient-centered Assessments, Cleveland, OH 5/18/02: Update on Congestive Heart Failure: Measuring and Interpreting Quality of Life; Kansas City, MO 7/21/02: American Hospital Association Cardiovascular Fellowship Symposium: Improving Doctor Patient Communication, San Diego, CA 8/19/02: The Future of Patient-centered data in Disease Management, Quality Assessment and Medical Decision-making, Cerner Corporation, Kansas City, MO 10/4/02: The Wilson Lectureship in Albuquerque New Mexico New Applications of Outcomes Research: Improving the Quality of Cardiovascular Care 10/13/02: 4th Annual Scientific Forum on Quality of Care and Outcomes Research – Changing the paradigm for selecting coronary revascularization: Identifying patients’ values and preferences for medical decision-making and creating new risk models for health status outcomes, Washington, DC 11/2/02: Keynote speaker, Preventative Cardiovascular Nurses Association (PCNA) KS and MO Fall Conference, Overland Park, KS 1/08/03: Saint Louis University’s Cardiovascular Grand Rounds: Transitioning Outcomes Research to Clinical Practice, Saint Louis, MO 2/07/03: Yale Cardiovascular Grand Rounds: Patient-Centered Assessments in Cardiovascular Disease – State of the Art and Future Directions, New Haven, CT 2/27/03: Keynote Speaker, Heart Failure Society of America – FDA Workshop: Key Issues in Trial Design for Devices in Heart Failure, Washington DC 3/5/03: Guest Lecturer, Amgen, Inc. Health Status Assessment in Heart Failure, Thousand Oaks, CA 3/29/03: ACC NCDR User’s Group Meeting Keynote Speaker: The Role of Patient-centered Assessments in Coronary Revascularization Chicago, IL 3/30/03: Chair, Mini-course on Psychosocial, post-traumatic issues and cardiovascular disease; 52nd ACC Scientific Sessions, Chicago, IL 4/1/03: Chair, Brown-bag Lunch – Measuring health status: Why Quality of Life is important; 52nd ACC Scientific Sessions, Chicago, IL 5/27/03: Kansas City Area Life Sciences Presentation to US House and Senate Staffers: Overview of Translational Research Kansas City, MO 6/13/03: Food and Drug Administration: Meet the Experts Session on Health Status and Quality of Life Bethesda, MD 7/22/03: Institute for Healthcare Improvement Breakthrough Series: Improving Care in Chronic Heart Failure: A National Priority Washington, DC 9/18/03: Kansas City Area Life Sciences Out of Lab Event: The Importance of Patient Outcomes in Translational Research Kansas City, MO 9/24/03: 7th Annual Scientific Sessions for the Heart Failure Society of America – Depression as a Predictor of Poor Outcomes 12.17/03: University of Iowa K-30 Lecture Series – Transitioning Outcomes Research into Practice: The Evolution of Patient-centered Outcomes and their Application as a Window into Patient Experience Iowa City, IA 12/17/03: University of Iowa Grand Rounds – Crossing the Quality Chasm: Using Outcomes Research to Advance the Quality of Care Iowa City, IA 1/6/04: Institute of Medicine Plenary Session on Crossing the Quality Chasm: Report of the Heart Failure Working Group, Washington, DC 3/19/04: Translating Outcomes Research to Practice: Doris Duke Clinical Scientists’ Meeting, Cold Spring Harbor, NY 4/2/04: Panel Speaker, Heart Failure Society of America – FDA Workshop: Issues in Unblinded Trials, Washington DC 5/15/04: 5th Annual AHA Scientific Forum on Quality of Care and Outcomes Research – Defining Novel Mechanisms to Measure Appropriateness in PCI, Washington DC 5/16/04: 5th Annual AHA Scientific Forum on Quality of Care and Outcomes Research – Update on the Institute of Medicine’s Crossing the Quality Chasm in CHF, Washington DC 10/15/04:Cardiovascular Grand Rounds, Mayo Clinic: Outcomes Research – Translating evidence to improve the quality of cardiovascular care, Rochester, MN 11/9/04: Meet the Experts: Developing a Career in Outcomes Research; 2004 Scientific Sessions of the American Heart Association, New Orleans, LA 11/9/04: Meet the Experts: Measuring Quality of Life; 2004 Scientific Sessions of the American Heart Association, New Orleans, LA 1/13/05: KU Center for Healthcare Informatics Grand Rounds – Healthcare Information Technology: Enabling Clinical Excellences Kansas City, KS 3/8/05: Co-Chair, Components of a Successful QI Program; 2005 Scientific Sessions of the American College of Cardiology, Orlando, FL 3/7/05: Co-Chair, Registries in Interventional Cardiology: Real World Assessments of Outcomes; 2005 Scientific Sessions of the American College of Cardiology, Orlando, FL 3/18/05: Emory Grand Rounds – New Frontiers in Outcomes Research, Atlanta, GA 3/24/05: Grand Rounds, Mid America Heart Institute - Novel Approaches to the Quantification of PCI Appropriateness, Kansas City, MO 3/31/05: Association of Independent Academic Medical Centers Annual Conference Plenary Speech: The Role of Outcomes Research in Advancing the Mission of an Academic Medical Center Amelia Island, FL 7/12/05: Leveraging Fellowship Research to a Career, University of Iowa K-30 Program Iowa City, IA 7/26/05: Mid America Coalition on Health Care: A cardiologist’s perspective on novel directions to improve the quality of care Kansas City, MO 8/30/05: New Frontiers in Outcomes and Quality of Care Research, UMKC Innovations Series, Stower’s Institute, Kansas City, MO 9/9/05: Co-Chair Methodology Working Group, ACC Appropriateness Criteria Summit, Chicago, IL 9/21/05: Keynote Presentation: Patient Registries: Strategies for Maximizing Registry Performance for Clinical and Commercial Use – Using Data to Improve the Quality of Care. Philadelphia, PA 11/3/05: Keynote Presentation: Gender and Racial Disparities in Cardiovascular Care and Outcomes – Heart Healthy Women & Disparities: Region VII Cardiovascular Conference of the Department of Health and Human Services; Kansas City, MO 11/15/05:Co-Chair, Demographic and Patient Characteristics: Health Policy and Outcomes Research American Heart Association Scientific Sessions, Dallas, TX 11/28/05:Cardiovascular Grand Rounds with School of Public Health, Saint Louis University – Crossing the Quality Chasm: Using Outcomes Research to Advance the Quality of Cardiovascular Care, St. Louis, MO 1/21/06: Michigan ACC Chapter Meeting: The Role of the Cardiologist in the Care of Diabetes; Ann Arbor, MI 1/30/06: Duke – ACC Think Tank on Dimensions of Cardiovascular Imaging Quality: Quality Measurement 101; Washington DC 2/10/06: University of Kansas Psychology Grand Rounds: Risks and Responses to Depression at the Time of Myocardial Infarction: A call to action; Kansas City, KS 3/14/06: American College of Cardiology Scientific Sessions: Implementing the Acute Care Guidelines at Your Hospital Atlanta, GA 4/17/06: Ethical Issues in Care for Persons with Advanced Heart Failure, Washington DC 5/02/06: HCA-CCMN 2006 Meeting: The Cycle of Success Continues: Novel Determinants of Patient Outcomes after PCI Nashville, TN 5/16/06: Medical College of Virginia Cardiology Grand Rounds: Outcomes Research as a tool for Improving the Quality of Care in Cardiology. Richmond, Virginia. 11/11/06: CAD in Women- Insights from PREMIER and other Registries. American Heart Association Symposium, Chicago, IL. 11/14/06: Appropriateness Measures: New Changes in the Practice of Cardiology. Plenary Session, American Heart Association Scientific Sessions. Chicago, IL. 12/7/06: Keynote Speaker, Kansas City Employer Brokers Professional Association Kansas City, MO 1/18/07: Cardiovascular Grand Rounds, University of Missouri, Columbia. Columbia MO. 3/24/07: Co-Chair, Medical Intervention after Coronary Intervention, American College of Cardiology Scientific Sessions I2 Summit, New Orleans, LA 3/25/07: Quality of Life Evaluation after ST-Elevation Myocardial Infarction, American College of Cardiology Scientific Sessions I2 Summit, New Orleans, LA 3/26/07: Psychological issues in Chronic Angina, American College of Cardiology Scientific Sessions, New Orleans, LA 3/27/07: Door to Balloon Initiatives: Learning how to make a Difference, American College of Cardiology Scientific Sessions, New Orleans, LA 3/27/07: How to Monitor my Heart Failure Patient with Health Status. American College of Cardiology Scientific Sessions, New Orleans, LA 4/25/07: The Rewards of Clinical Research, University of Kansas Resident Research Keynote Speech, Kansas City, KS 5/10/07: Translational Research 8th Annual Scientific Forum, Washington, DC 5/31/07: Exercise Testing/Functional Capacity/ Status Assessment, HFSA/FDA Workshop, Bethesda, MD 9/30/07: MedAxiom Annual Meeting: New Approaches to Quantifying the Quality of Outpatient Care – IC3 Aspen, CO 10/8/07: Leveraging the Informed Consent Document as a Means for Delivering Ix Therapy in Routine Clinical Care. Annual Scientific Sessions of Ix Therapy; Park City, UT. 10/18/07:Recognizing and developing innovative solutions to the discontinuation of thienopyridines after DES. Spanish Society of Cardiology Annual Meeting; Madrid, Spain. 10/20/07:Improving Door-to-Balloon Times: Experiences from the Mid America Heart Institute. Spanish Society of Cardiology Annual Meeting; Madrid, Spain. 11/4/07: First do no harm Sunday Morning Symposium, Moderator, American Heart Association Scientific Sessions, Orlando, FL 11/4/07: Late-Breaking Outcomes Research – Implications for Clinical Practice, Moderator, American Heart Association Scientific Sessions, Orlando, FL 11/6/07: Cardiovascular Seminar on Quality, Moderator, American Heart Association Scientific Sessions, Orlando, FL 11/6/07: Cardiovascular Seminar on Quality, Are we ready for Pay for Performance, American Heart Association Scientific Sessions, Orlando, FL 11/9/07: Patient-Centered Healthcare. World Congress of Consumer-based Healthcare, Washington DC 12/1/07: The Risk-Treatment Paradox. Excellence in Interventional Cardiology, Vancouver BC 12/9/07: The Promises and Pitfalls of Genetics in Coronary Artery Disease. 40th Annual New York Cardiovascular Symposium, New York, NY 12/13/07:Outcomes Research and the Path to Better Patient Care. Saint Luke’s Hospital Surgical Grand Rounds, Kansas City, MO 2/7.08: The Role of Outcomes Research in a Translational Research Agenda with Geneticists. Children’s Mercy Hospital, Kansas City, MO 3/10/08: Operationalizing Morbidity and Mortality Measures for Individual, Physician-level Reporting National Quality Forum, Washington DC 3/12/08: Personalized Medicine, Keynote Lecture, Saint Luke’s Health System Annual Board Meeting. Kansas City, MO 3/13/08: Personalized Medicine, Cardiovascular Grand Rounds, Mid America Heart Institute, Kansas City, MO 3/27/08: Public Reporting and its Implications for the NCDR, 9th Annual NCDR Meeting, Chicago, IL 3/28/08: Collaborative Research, NIH-FDA Symposium on Polycystic Kidney Disease, Chicago, IL 3/28/08: Bridging the Inpatient and Outpatient Care Environments for Coronary Artery Care, 9th Annual NCDR Meeting, Chicago, IL 3/29/08: Do we have the COURAGE not to revascularize the elderly. A Debate with Donald Baim for the Society of Geriatric Cardiology, Chicago, IL 3/30/08: Moderator, Drug Eluting Stents I, SCAI/ACC Scientific Sessions, Chicago, IL. 3/31/08: Panelist, Quality Indicators in Heart Failure, ACC Scientific Session, Chicago, IL. 3/31/08: Chair, Outpatient Quality of Care, ACC Scientific Session, Chicago, IL. 4/1/08: Panelist, Quality in Cardiovascular Imaging, ACC Scientific Session, Chicago, IL. 5/16/08: Cardiovascular Grand Rounds, Mayo Clinic, Rochester MN 6/24/08: Keynote Speaker, APPROACH Meeting, Alberta, Canada 6/28/08: Plenary Speaker, Cardiovascular Disease in the Elderly, “Application of COURAGE to the elderly”. Washington DC 8/8/08: What is Effectiveness and How Should we Measure it? Cardiac Society of Australia and New Zealand, Adelaide, Australia 8/8/08: Application of Health Status Measures in Cardiac Care Cardiac Society of Australia and New Zealand, Adelaide, Australia 8/9/08: Managing Stable CAD with COURAGE Cardiac Society of Australia and New Zealand, Adelaide, Australia 10/21/08: Grand Rounds, University of Michigan: New Directions for Outcomes Research, Ann Arbor, MI 10/22/08: Grand Rounds, Christiana Healthcare, Transforming the Quality of Medical Care through Outcomes Research, Wilmington, DE 10/28/08: Medical Director’s Institute, Quantifying the Quality of Care in the Outpatient Setting – IC3, Tyson’s Corner, VA 11/8/08: Plenary Speaker, Overview of an Ideal Outcomes Training Program, Scientific Sessions of the American Heart Association, New Orleans, LA 11/11/08: Moderator, Give me help on my Research Project Meet the Experts Session, Scientific Sessions of the American Heart Association, New Orleans, LA 11/11/08: Plenary Speaker, Applying Secondary Prevention in Practice: Beyond Phase 2 to Improve Care and Outcomes, Scientific Sessions of the American Heart Association, New Orleans, LA 11/12/08: Moderator, Late Breaking Clinical Trials IV, Scientific Sessions of the American Heart Association, New Orleans, LA 12/7/08: The Heart – Genomics and Personalized Medicine, What the Primary Care Physician Needs to Know. Kansas City, MO 12/21/08: Cardiovascular Grand Rounds, Washington University, Saint Louis: The Risk-Treatment Paradox – Using Outcomes Research to Advance the Quality of Cardiovascular Care. Saint, Louis, MO 2/9/09: Health Status as Outcomes for Clinical Trials, a debate with Rob Califf, Beaver Creek, CO 2/10/09: Appropriate Use Criteria for PCI, Beaver Creek, CO 3/6/09: Medical Grand Rounds – Integris/Baptist Medical Center, Oklahoma City, Oklahoma 3/29/09: Plenary Speaker, Risk Assessment – The Cornerstone of Appropriate Use Criteria, Scientific Session of the American College of Cardiology/I2, Orlando, FL 3/29/09: Moderator, Report Cards for Public Reporting of PCI Outcomes, Scientific Session of the American College of Cardiology/I2, Orlando, FL 3/30/09: Moderator and Panelist, Meet the Experts Session on Real-time Shared Decision-making for Coronary Revascularization, Scientific Session of the American College of Cardiology, Orlando, FL 3/31/09: Plenary Speaker, Quality of PCI – Are We Measuring the Right Thing? Angina and Quality of Life, Scientific Session of the American College of Cardiology/I2, Orlando, FL 5/4/09: Cardiovascular Grand Rounds, Weil-Cornell University, New York NY 5/8/09: Cardiovascular Grand Rounds, Yale University, New Haven, CT 6/1/09: Speaker, Measuring Quality of Life, European Society of Cardiology Heart Failure, Nice, France 9/11/09: Implications of COURAGE and BARI 2D in Clinical Practice. International Heart Forum Beijing 2009, Beijing China 9/15/09: Quality of Life: Is there any other meaningful endpoint in heart failure? Heart Failure Society of America, Boston, MA 9/22/09: Difficult Patients: Clinical Dilemmas in Interventional Cardiology – The Asymptomatic Diabetic Patient with Evidence of Ischemia: Cath or no Cath? Transcatheter Cardiovascular Therapeutics, San Francisco CA 9/24/09: Guidelines, Appropriateness Criteria, Cost and Comparative Effectiveness: The New Medical Lexicon? Transcatheter Cardiovascular Therapeutics, San Francisco CA 9/24/09: Featured Clinical Trials: NEVO RES-ELUTION I QOL: Formal Quality of Life Assessment from a Prospective Randomized Trial of a Novel Sirolimus-eluting Stent and a Paclitaxil-eluting Stent Transcatheter Cardiovascular Therapeutics, San Francisco CA 10/21/09: Visiting Professor, Department of Psychology, Tilberg University, Tilberg, the Netherlands 10/23/09: Keynote speaker, Vascular rounds, Tilberg Surgery Society, Tilberg, Netherlands 11/14/09: Training in Outcomes Research, American Heart Association Scientific Sessions, Orlando, FL 11/15/09: Moderator, Late-breaking Clinical Trials, American Heart Association Scientific Sessions, Orlando, FL 12/5/10: Outcomes Research to Support Personalized Health, Kansas City University of Medicine and Biosciences Annual Scientific Meeting, Kansas City, MO 2/18/10: Quantifying Appropriateness for Coronary Revascularization in Clinical Practice, ACC-STS-Pacific Business Group on Healthcare Conference, San Francisco, CA 2/20/10: Keynote Speaker, American Heart Association Heart Ball, Kansas City, MO 2/23/10: Insights into the Appropriateness of cardiac procedures: How can it be measured and improved? Imaging: the ASNC Session, CardioEgypt, Cairo, Egypt 2/24/10: Overview of Patients’ Perspectives of CAD: How to Assess and Why its Important, A Real-world co-morbidities & Outcomes of ACS, CardioEgypt, Cairo, Egypt 2/25/10: Highlights from PREMIER: A US Registry of Outcomes after Discharge. The Center of Excellence: Registry for Acute Coronary Syndrome, CardioEgypt, Cairo, Egypt 2/25/10: Update on the Management of stable CAD after BARI 2D and COURAGE, State of the Art Lecture: Management of Stable CAD, CardioEgypt, Cairo, Egypt 3/16/10: Speaker, How can patient choice be linked to informed consent? Patient-Centered Care Symposium, American College of Cardiology Scientific Sessions, Atlanta, GA 3/16/10: Panelist, The Past, Present and Future of Cardiac Registries, Meet the Experts Section, American College of Cardiology Scientific Sessions, Atlanta, GA 4/2/10: Cardiovascular Grand Rounds, Northwestern University, Chicago, IL 4/8/10: Interventional Grand Rounds, Innovations in Informed Consent, Mayo Clinic, Rochester, MN 4/22/10: Outcomes Research as the Terminal Phase of Translational Research, Kansas City Area Life Sciences Research Symposium, Kansas City, MO 4/23/10 Cardiovascular Grand Rounds, Baylor University the Heart Hospital, Plano, TX 5/7/10: Cardiovascular Grand Rounds, Prairie Heart, University of Illinois, Springfield, IL 5/12/10: Interventional Grand Rounds, Henry Ford Hospital, Detroit, MI 6/4/10: Interventional Grand Rounds, Washington University, Saint Louis, MO 6/8/10: Cardiovascular Grand Rounds, Duke University, Durham NC 6/10/10: Plenary Speaker, Midwest Consortium on Translational Research, University of Kansas, Kansas City, MO 7/26/10: Invited Speaker, Kaiser Department of Research Grand Rounds, Oakland, CA 7/27/10: Medicine Grand Rounds, Kaiser – San Francisco, San Francisco, CA 7/28/10: Interventional Grand Rounds – San Francisco, CA 8/13/10: Plenary Speaker, Management of Stable Ischemic Heart Disease, Implications of COURAGE and BARI 2D. International Heart Forum Beijing 2010, Beijing China 8/13/10: Appropriateness of Coronary Revascularization, Selecting the Right Patient, International Heart Forum Beijing 2010, Beijing China 9/23/10: Revascularization in Stable Ischemic Heart Disease – Predictors of Crossing Over to PCI, Transcatheter Cardiovascular Therapeutics Conference, Washington DC 10/01/10: Cardiovascular Grand Rounds, Baystate Medical Center, Springfield MA 11/13/10: Moderator, Early Career Workshop, American Heart Association, Chicago, IL 11/14/10: Moderator, Integrated Insights into Clinical Trials, American Heart Association, Chicago, IL 11/15/10: Moderator and Speaker, Role of Health Status in Clinical Research and Patient Management, American Heart Association, Chicago, IL 11/17/10: Panelist, Controversies in Outcomes Research, American Heart Association, Chicago, IL 11/18/10: Keynote Speaker, Translational Research, University of Iowa, Iowa City, IA 12/02/10: Speaker, Clinical and Translational Research Conference, University of Kansas, Kansas City, KS 01/06/11: Keynote Speaker, Personalize Medicine Conference, Washington DC 01/27/11: Neurology Grand Rounds, UCLA School of Medicine, Los Angeles, CA 01/28/11: General Internal Medicine Conference, UCLA School of Medicine, Los Angeles, CA 03/09/11: Grand Rounds, Fuwai Hospital, Beijing China 03/10/11: International Conference on Outcomes Research for Chinese Government, Beijing, China 03/18/11: Grand Rounds, New York University, New York, NY 04/01/11: Plenary Speaker, NCDR User’s Conference, New Orleans, LA 04/03/11: Patient-centered Outcomes in ACS, International Pacific Asian Session, American College of Cardiology, New Orleans, LA 04/05/11: Meet the Experts, Quality in Heart Failure, American College of Cardiology, New Orleans, LA 04/05/11: Panelist and Speaker, Revascularization for Multi-vessel CAD, American College of Cardiology, New Orleans, LA 04/14/11: Cardiovascular Grand Rounds, Brigham and Women’s Hospital, Harvard Medical School, Boston MA 04/15/11: Cardiovascular Grand Rounds, Beth-Israel Deaconess Medical Center, Harvard Medical School, Boston MA 04/29/11: Medical Grand Rounds, University of Wisconsin Madison Medical Center, Madison, WI 5/11/11: Plenary Speaker, AHA Annual Scientific Forum on Quality of Care and Outcomes, Integrating Risk Prediction Within the Flow of Patient Care, Washington DC 5/19/11: Medical Grand Rounds, University of Vancouver, Vancouver BC, Canada 6/21/11: Visiting Professor and Speaker, Centers for Disease Control, Atlanta Georgia 7/25/11: Speaker, HICTR Conference on Translational Research, University of Kansas Medical School, Kansas City, MO 8/11/11: Plenary Speaker, National Cardiovascular Center of China National Conference, Strategies for Managing Stable Coronary Artery Disase, Beijing China 8/12/11: Plenary Speaker, National Cardiovascular Center of China National Conference, Patient-reported Outcomes in Coronary Artery Disease, Beijing China 9/16/11: Plenary Speaker, Health Management Academy, Peronalized Medicine in Clinical Care: Clinical and Economic Benefits of Tailored Therapy, Dear Park, UT 9/22/11: Speaker, Genentech Invited Speaker Series, New Approaches to Translational Medicine, San Francisco, CA 10/4/11: Cardioavscular Grand Rounds, New York University School of Medicine, Using Outcomes Research to Advance the Quality of Cardiovascular Care, New York, New York 11/3/11: Keynote Speaker, Optum Healthcare, The COURAGE Trial and its Implications, Las Vegas, NV 11/8/11: Discussant, Identifying High-risk Patients, Transcatheter Cardiovascular Therapeutics Annual Scientific Sessions, San Francisco, CA 11/9/11: Panelist, Clinical Trial Interpretation, Transcatheter Cardiovascular Therapeutics Annual Scientific Sessions, San Francisco, CA 11/10/11:Keynote Speaker, Drivers of Revascularization in Stable Ischemic Heart Disease, Transcatheter Cardiovascular Therapeutics Annual Scientific Sessions, San Francisco, CA 11/10/11:Discussant, Clinical Trials in Practice, Transcatheter Cardiovascular Therapeutics Annual Scientific Sessions, San Francisco, CA 11/14/11: Meet the Trialists, American Heart Association Annual Scientific Sessions, Orlando FL 11/16/11: Plenary Speaker, Challenges in the Management of Coronary Artery Disease – Shared Decision-making Tools in Stable CAD, American Heart Association Annual Scientific Sessions, Orlando FL 12/10/11: Plenary Speaker, Quality Metrics: Tools and Utilization, American College of Cardiology Wisconsin Chapter Annual Meeting, Fontana, WI. 12/12/11: Speaker, Young President’s Organization, What is Outcomes Research, Kansas City MO 2/1/12: Cardiovascular Grand Rounds, Massachussetts General Hospital, Boston MA 2/13/12: Speaker, New Paradigms for Translational Research in Academic Medical Centers, Institute of Medicine, Washington, DC 3/5/12: Keynote Speaker, Providence Health System Annual CV Meeting, Updates on Appropriateness of Coronary Revascularization, Missoula Montana 3/24/12: Speaker, Personalized Medicine, Heart of Innovations at the Annual Scientific Sessions of the American College of Cardiology, Chicago, IL 3/25/12: Discussant, Clinical Outcomes in Acute Coronary Syndromes, Annual Scientific Sessions of the American College of Cardiology, Chicago, IL 3/26/12: Discussant, Comparative Effectiveness Research, Annual Scientific Sessions of the American College of Cardiology, Chicago, IL 4/11/12: Buxton Lectureship, University of Texas Medical Branch Surgical Grand Rounds, Galveston TX 4/20/12: Plenary Speaker, CTSA Panel on Personalized Evidence-based Medicine, Annual CTSA Meeting, Washington DC 4/26/12:Keynote Speaker, Health Managament Academy, Carlsbad CA 4/30/12: Keynote Speaker, Frontiers/KCALSI Annual Life Sciences Retreat, Leveraging Outcomes Research to Improve the Quality of Care, Kansas City, KS 8/9/12: Plenary Speaker, China Heart Conference “Patient-Reported Outcomes: The Growing Importance of the Patients' Voice in Clinical Research”, Beijing, China 8/9/12: Plenary Speaker, China Heart Conference “Using Risk Models to Guide Practice Decisions”, Beijing, China 8/12/12 WuHan International Forum for Diabetes and Related Diseases Summit: “Quality Care in Diabetes Management During ACS Hospitalization: Insights and Opportunities”, WuHan China 9/29/12: Keynote Speaker: “Personalized Medicine to Improve the Quality and Consistency of Care” MI Chapter ACC Annual Meeting, Traverse City, MI 10/11/12:Plenary Speaker, “Collaborative Outcomes Research between the US and China”, Edgar Snow Conference, Beijing China 10/22/12: Moderator, The Drug-Eluting Stent Summit: Appropriate Utilization Of Current Generation Devices: Session IV. PCI and DES in Stable Ischemic Heart Disease: Moderator. TCT Annual Scientific Sessions, Miami, FL 10/22/12: Lecturer, The Drug-Eluting Stent Summit: Appropriate Utilization Of Current Generation Devices: Session IV. PCI and DES in Stable Ischemic Heart Disease. Debate: BMS Should be Used in Patients at Low-risk for TVR. TCT Annual Scientific Sessions, Miami, FL 10/22/12: Lecturer, Core Training Curriculum In Clinical Research: Session IV. Standardized Data Definitions, Risk Stratification, and Personalized Medicine. QoL: Should this be the key parameter in Choosing Thearpy? TCT Annual Scientific Sessions, Miami, FL 10/22/12: Lecturer, Core Training Curriculum In Clinical Research: Session IV. Standardized Data Definitions, Risk Stratification, and Personalized Medicine. . Personalized Medicine: Current tools and the Future of Clincial Research in Practice.TCT Annual Scientific Sessions, Miami, FL 11/4/12: Speaker Cardiovascular Seminar, Challenges and Potential Solutions in a Cardiovascular Guidelines, Is it time to rethink guideline development, 2012 Annual Sceintific Sessions of the Maerican Heart Association, Los Angeles, CA 11/5/12: Speaker, Cardiovasuclar Seminar, Tools to improve Appropriate Use Criteria Performance, 2012 Annual Sceintific Sessions of the Maerican Heart Association, Los Angeles, CA 11/6/12: Speaker, Cardiovascular Seminar, Surrogage Metrics: Past and Presnet Problems: Surrogate Outcomes: Important Insights or Expensive Distractions. 2012 Annual Sceintific Sessions of the Maerican Heart Association, Los Angeles, CA 11/7/12: Plenary Speaker, Analyzing Risk Associated with Treatment Options for Multivessle Coronary Disease; The Heart Team in Action: From Evidence to Everyday Decision Making in Ischemic Heart Disease. 2012 Annual Sceintific Sessions of the Maerican Heart Association, Los Angeles, CA 11/28/12: Using Evidence-based Prediction Models to Improve Care, HCA C3 Physician Leadership Comference, Nashville, TN 12/7/12 Medicine Grand Rounds, Saint Louis University, Personalized Medicine to Improve the Quality of Care: Opporutnities and Obstacles, St. Louis, MO 12/7/12: Heart Failure Network, Outcomes Research in Congestive Heart Failure, Washington University, St. Louis, MO 12/8/12: Plenary Speaker, Washington University Heart Failure Conference, Personalized Medine to Improve Care in Heart Failure, St. Louis, MO 2/26/13: Keynote Speaker, 5th Annual Methods Seminar in Outcomes Research: Patient Safety, Quality Improvemmetn and Evidence Implementation Research, University of Alabama, Birmingham, AL 3/9/13: Meet the Experts Session, How to Set Up and Acute Coronary Syndrome Performance Improvement Program, American College of Cardiology Scientific Sessions, San Francisco, CA 3/9/13: Mentor, FIT Forum II: Mix n’ Mingle, American College of Cardiology Scientific Sessions, San Francisco, CA 3/10/13: Speaker, Should We Monitor Patients with Quality of Life Instruments? ACC Scientific Sessions Symposium: How Should We Monitor the Patient with Heart Failure? San Francisco, CA 3/10/13: Protagonist: Quality of Life - What about the Patient? Quality of Life and Patient Satisfaction in a Clinical Focus entitled Management Dilemmas in Chronic Coronary Heart Disease, American College of Cardiology Scientific Sessions, San Francisco, CA 4/18/13:Speaker, Implementation of Comparative Effectiveness Research. University of Washington Comparative Effectiveness Conference, St. Louis, MO 4/25/13:Evolving Strategies for Quality Assessment and Improvement, Genentch, San Francisco, CA 4/28/13: Overview of Peronsalized Medicine in NCDR: Opportunities to Improve the Safety and Quality of PCI. American College of Cardiology CQC/NCDR meeting. Washington DC 5/3/13: Quality of Life in ISCHEMIA, China Kick-off Meeting for ISCHEMIA Trial, Beijing, China 5/16/13: Moderator, Young Investigator’s Award Competition, 16/13AHA Annual Scientific Forum on Quality of Care and Outcomes Research, Baltimore, MD 5/16/13: Moderator, Evolution of Medical Journals – Ways to improve Circulation: CV Quality and Outcomes, AHA Annual Scientific Forum on Quality of Care and Outcomes Research, Baltimore, MD 5/16/13: Expert, Career Development, AHA Annual Scientific Forum on Quality of Care and Outcomes Research, Baltimore, MD 5/16/13: Moderator, Joint AHA-Australian Conference on PCI Quality and Regstries: NCDR and CADOSA, AHA Annual Scientific Forum on Quality of Care and Outcomes Research, Baltimore, MD 5/29/13: Speaker, Translating Comparative Effectiveness Research to Practice. Joint ACC CQC/NCDR Meeting Heart House, Washington DC 6/24/13;Speaker and Moderator. FDA Health of Women Conference, Peronalized Medicine to Improve the Health and Outcomes of Women in Cardiovascular Disease, Silver Springs, MD 7/9/13: CV Grand Rounds, Opportunities for Personalized Medicine to Improve the Outcomes and Consistency of Care. Marshall University, Huntington WV 7/15/13: Overview of the Appropriate Use Criteria for Revascularization. 1st Annual Geoffrey Hartzler International Interventional Conference. Maui, HI 7/15/13: The Great Debate: Do we need the AUC, or is the Hippocratic Oath enough? Pro AUC stance. 1st Annual Geoffrey Hartzler International Interventional Conference. Maui, HI 7/17/13: Personalized Medicine to Improve the Safety and Outcomes of PCI. 1st Annual Geoffrey Hartzler International Interventional Conference. Maui, HI 7/29/13: Dissemination and Implenetation fo Comparative Effectiveness Research in Clinical Care, Comparative Effectiveness Conference, Portland, OR 8/4/13: Personalizing Care for PCI, Hongzhou Interventional Conference, Hongzhou China 9/4/13: Outcomes Resaerch as a Foundation for Personalized Medicine, University of Tilberg Vascular Rounds, Tilberg, the Netherlands 9/12/13: Delivering Personalized Medicine Today, Plenary Spearker University Health Consortium Cardiobascular Conference, Ohios State Univeristy Ohio 9/18/13: Personalized Medicine to Improve the Quality of Cardiovascular Care, University of Kansas Cardiovascular Grand Rounds, Kansas City, KS 10/28/13: Quantifying Quality of Life in Stable Ischemic Heart Disease, TansCatheter Therapeutics Conference, San Francisco, CA 10/29/13: Benefits of Revascularization in Improving QoL in SIHD: Metrics, Magnitude and Patient Selection, TansCatheter Therapeutics Conference, San Francisco, CA 10/30/13: Defining the Optimal Role of AUC in your Cath Lab, TansCatheter Therapeutics Conference, San Francisco, CA 10.30/13: What Really Matters: Intergrating Hard Endpoints, Quality of Life and Patient Preferences; TansCatheter Therapeutics Conference, San Francisco, CA 11/16/13: Plenary Presentation on New Paradigmas and Opportunities in Research - Determining What Matters to Patients - Using Patient Reported Outcomes; American Heart Association Scientific Sessions, Dallas TX 11/16/13: Young Investigators Forum - My Grant Just Got Rejected!! Now What?!? American Heart Association Scientific Sessions, Dallas TX 10/18/13: Engaging the Patient in the Decision Making for Acute Ischemic Stroke; American Heart Association Scientific Sessions, Dallas TX 12/11/13: Using Outcomes Resaerch and Personalized Medicine to Improve the Quality of Care – University of Alberta Cardiovascular Grand Rounds, Alberta Canada 12/11/13: Interpreting Patient-reported Outcomes – An Update on the State of the Art; Univesrity of Alberta Research Conference, Alberata, Canada 12/12/13: Guidelines, Performance Measures and the Appropriate Use Criteria, The Heart Conference, Kansas City, MO 12/16/13: Personalized Medicine – Challenges and Opportunities to Improve Care, University of London Cardiovascular Grand Rounds, London, England 2/4/14: Personalized Medicine in the Cath Lab to Improve Safety and Outcomes, Cardiovascular Grand Rounds, University of Pittsburgh Medical Center, Pittsburgh PA 2/14/14: Use of Personalized Medicine to Improve Safety and Outcomes of PCI and Stroke, UCSD Neurology Grand Rounds, San Diego, CA 3/27/14: Panel Presenter on Academic Careers and Publication for the Association of Black Cardiologists, Washington DC, 3/29/14: ‘TED’ Talk on Stable Ischemic Heart Disease Guidelines, ACC Scientific Sessions, Washington DC 4/4/14: Shared Medical Decision-Making – The Pinnacle of Patient-Centered Care. EuroHeart 2014, Stavenger Norway 4/4/14: Use of Health Status in the ‘Real World’ – Benefits and Barriers, EuroHeart 2014, Stavenger Norway 4/4/14: Moderator, Prevention: Is it Mind over Matter? EuroHeart 2014, Stavenger Norway 4/9/14: Personalized Medicine to Improve the Safety and Outcomes of PCI, Grand Rounds, Sharp Healthcare System, San Diego CA 4/11/14: Use of Big Data to Improve Care, American Academy of Ophthalmology Mid-Year Forum, Washington DC 4/17/14: Personalized Medicine to Improve Care, Universisty of Kansas – Wichita Research Form Plenary Speaker, Wichita KS 5/1/14: Use of Personalzed Medicine to Achieve the Triple Aim of Healthcare, Heatlh Management Academy Chief Medical Officers Forum, Key Largo, FL 5/28/14: Speaker, The Ethics and Practice of Informed Consent and Shared Decision-Making in PCI. Annual Scientific Sessions of the Society for Coronary Angiography and Intervention. Las Vegas, NV 6/1/14: Speaker, Cultural Barriers to Translating Outcomes Research to Clinical Practice. National Heart, Lung and Blood Institute Think Tank on Cardiovascular Outcomes Research; Baltrimore MD 6/2/14: Speaker, The Editorial Process – What happens after submission? Workshop on Communication of Science; American Heart Association Annual Scientific Forum on Quality of Care and Outcomes Research, Baltimore, MD 6/3/14: Plenary speaker and moderator, Entrepreunership and Quality Improvement. American Heart Association Annual Scientific Forum on Quality of Care and Outcomes Research, Baltimore, MD 6/3/14: Speaker, Outcomes 2.0: What to measure beyond mortality and readmission. American Heart Association Annual Scientific Forum on Quality of Care and Outcomes Research, Baltimore, MD 6/4/14: Panelist, Work/Life Balance in Outcomes Research. American Heart Association Annual Scientific Forum on Quality of Care and Outcomes Research, Baltimore, MD 7/28/14: Plenary Speaker, CMS Patient and Family Engagement Affinity Group on Patient Family and Engagement and Informed Consent 9/20/14: Spekaer, At the Heart of Success: Kansas City Reginoal Meeting, ‘Appropriateness in the Cath Lab”, Kansas City, MO 9/22/14: Evening Keynote Speaker, APPROACH Workhop. ‘Entrepreunership as a Means for Translating Resaerch into Pracitce”, Calgary, Alberta, Canada 9/23/14: University of Calgary Grand Rounds, “Translating Evidence into Practice: Barriers and Opportunities to Delivering Personalized Medicine”, Calgary, Alberta, Canada 10/7/14 Keio University Cardiology Grand Rounds, “Personalized approaches to Patient Selection for Trans-Aortic Valve Replacement” Tokyo, Japan 10/9/14 NIDDK Conference on Clincial Trial Outcomes in Diabetes Trials, Panelist. National Institutes of Health, Bethesda MD 10/17/14 University of Nebraska Medical Center Cardiology Grand Rounds, “Translating Evidence into Practice: Barriers and Opportunities to Delivering Personalized Medicine”, Omaha, NE 11/1/14: California ACC Chapter Meeting Keynote Speaker “Translating Evidence Into Practice: Barriers and Opportunities in Personalized Medicine”, Los Angeles, CA 11/18/14: Speaker, “Choosing Optimal PCI Strategies based on Risk”, AHA Scientific Sessions, Chicago, IL 11/18/14: Speaker and Panelist, “Using Big Data to Support Decision Support”, AHA Scientific Sessions, Chicago, IL 11/20/14: CHINA PEACE-II National Kick-off Meeting, “Delivering High-Quality Care: Challenges and Strategies”, Wuhan Medical Center, Wuhan, China 12/2/14: Citywide Cardiology Grand Rounds, “Challenges and Opportunities for Providing Personalized Medicine: An Example in PCI”, Toronto, Canada 12/3/14: Grand Rounds at Saint Michael’s, “Using Outcomes to Advance Quality: Personalixe Medicine and Shared Medical Decision-Making”, Toronto Canada 12/3/14: Grand Rounds at Toronto General Hospital: “The Landscape of Quality Assessment/Improvement: Where We Are and Where We’re Going”, Toronto, Canada 12/17/14: Vanderbilt Cardilogy Grand Rounds: “Translating Evidence into Practice: Barriers and Opportunities to Delivering Personalized Medicine”, Nashville, TN 1/28/15: Plenary Speaker: Personalized Evidence to Improve Outcomes, Patient Reported Outcomes in Surgery Conference, Washington DC 1/30/15: Keynote s/peaker, Our Moral Imperative to Improve the Quality of Care: Where We are and Where We are Going, 18th Arrhythmia-Plus Conference, Whistler Canada 2/2/15: Grand Rounds Speaker, Realizing the Vision of Patient-Centered Care, BC Centre for Improved Cardiovascular Health, Vancouver, Canada 2/6/15: Keynote Speaker, The Role of Entrepreneurship in Improving Healthcare, KC Today, Kansas City, MO 2/9/15: Plenary Speaker, Outcomes and Quality of Life Relevant to Older Adults with Multiple Comorbid Conditions, NIH Multimorbidity in Older Adults with Cardiovascular Disease, Washington DC 2/20/15: Plenary Speaker, Applying Personalized Medicine in the Cath Lab: Improving Reliability, Safety and Cost-Effectiveness of Care, BJC Safety Conference, Saint Louis, Missouri 3/12/15: Keynote Speaker, Engaging Physicians in Quality Improvement, NCDR User’s Conference, ACC Scientific Sessions, San Diego, CA 3/4/15: Speaker, Re-Engineering Scientific Research, ACC Scientific Sessions, San Diego, CA 3/15/15: Speaker, Challenges in Estimating Risk and Prognosis in Heart Failure, ACC Scientific Sessions, San Diego, CA 3/16/15: Speaker, Eliminating Guesswork – Using Tools to Guage Procedural Risk, ACC Scientific Sessions, San Diego, CA 3/31/15: Grand Rounds Speaker, The Use of Big Data to Improve Clincial Care, University of Kansas Departement of Preventative Medicine 4/3/15: Cardiovascular Grand Rounds, Barriers and Opportunties to Deliver Precision Medicine in Clincial Practice – A Case Example in PCI, the Ohio State University, Columbus, OH 4/8/15: UMKC School of Dentistry Grand Rounds, The Role of Outcomes Research in Improving Clinical Care, UMKC Dental School, Kansas City, MO 4/23/15: Guest Lecturer, Use of Health Status Measures in Clinical Trials, Clinical Trials Course, UMKC Department of Bioinformatics and Personalized Medicine, UMKC School of Medicine, Kansas City, MO 5/8/15: Keynote Speaker, KU Medical School Research Day, Developing a Career in Clinical Research, University of Kansas Medical School, Kansas City, MO 5/18/15: Keynote Speaker: USASBE Midwest Conference, Entrepreneurship as a Means for Translating Discovery to Practice, UMKC Bloch School, Kansas City, MO 5/28/15: Plenary Speaker, Interpretation of the KCCQ in PARADIGM-HF, Novartis International Webinar 6/5/15: Cardioavascular Grand Rounds, Barriers to the Implementation of Precision Medicine, University of Utah, Salt Lake City, MO 6/11/15: Keynote Speaker, COAP Annual Meeting, Barriers to the Implementation of Precision Medicine, Seattle WA 6/16/15: Cardiovascular Section Meeting, Use of Precision Medicine to Improve Safety in PCI, Torrance Medical Center, Los Angeles, CA 6/18/15: Roger and Laura Meier Visiting Professorship, Barriers to the Implementation of Precision Medicine: An example in the setting of PCI, University of Oregon, Portland, OR 6/18/15: Cardiovascular Fellowship Conference, Use of Patient-Reported Outcomes in Research and Clincial Care, University of Oregon, Portland, OR 7/31/15: National Center for Cardiovascular Disease in China, How to Develop and Disseminate Risk Models to Improve Clinical Care, Beijing China 8/6/15: Plenary Speaker, China Heart Conference, Developing a Passion for Resarch: How to become a Successful Outcomes Researcher, Beijing, China 9/30/15: Plenary Spearker, University Health Counsortium Annual Meeting, “The Use of Personalized Medicine to Improve Value in the Coronary Catherization Laboratory’ Orlando Florida 10/1/15: Plenary Speaker, Exponential KC Conference, Kansas City, MO 10/12/15: Presentor, TCT Conference. ‘The Case for Moving QoL ‘Front and Center’ in RCTs, San Franssco, CA 10/14/15: Discussant, TCT Conference, The Digital Health Revolution, San Francisco, CA 10.14.15: Presenter and Discussant FDA Panel on Bioresorbable Stents, TCT Conference, “Incorporating QoL and PROs in the Device Redulatory Approval Process”, San Francisco, CA 10.15.15: Grand Rounds, Stanford Clinical Excellence Research Center, The Challenges and Opportunities for Precision Medicine to Improve the Value of Healthcare”, Palo Alto, CA 10/23/15, Grand Rounds, University of Odense Hospital, “Precision Medicine in PCI: Challenges and Opportunities”, Odense Denmark 10/27/15: Cath Lab Conference, Univesrity of Columbia Mecical Center, “Precision Medicine and PCI: Reducing Variabilty and Improving Quality”, New York, New York 11/4/15: Panelist, KU Center for Health Services Research, University of Kansas, Kansas City, KS 11/8/15: Moderator, Outcomes in Peripheral artery Disease and the Treatmetn Strategies that Drive Them, American Heart Association Scientific Sessions, Orlando FL 11/9/15: Moderator, PROMise for the Future: Patient-Reported Outocme Measures in Cardiovascular Disease, American Heart Association Scientific Sessions, Orlando FL 11/9/15: Speaker, PROMs in Routine Clinical Practice, American Heart Association Scientific Sessions, Orlando FL 11/10/15: The next Bith Thing in Precision Medicine (QCOR Council), American Heart Association Scientific Sessions, Orlando FL 11/10/15: Discussant Late-Breaking Clincial Trials, Angian and the Quality of Life Following PCI iwht Incomplete Revasucliarzation: Results from RIVER PC , American Heart Association Scientific Sessions, Orlando FL 11/20/15: Keynote lecture, American Academy of Orthopedics, “Use of Patient Reported Outcomces Measures in Clinical Practice,” Washington DC 12/7/15: Grand Rounds, “Use of Precision Medicine to Improve the Value or Cardiac and Stroke Care”, Regional Quality Meeting for the Provincial Health Board, Vancouver BC, Canada 12/7/15: Speaker, “Variability in Clinical Care – When it is Good and When it is Bad”, Vicor Steering Committee Meeting, Vancouver, BC, Canada 12/11/15: Speaker, “Why wait for Genomics? The Application of Personalized Medicine in 2015”, Robert D. Conn Heart Conference, Kansas City, MO 1/7/16: Invited Speaker, “Development of Risk Models”, China PEACE Investigators, Beijing China 1/22/16: Grand Rounds, University of Pennsylvania, “The Potential for Precision Medicine to Improve Value and Decrease Variability – A Case Study in PCI”, Philadelphia PN 2/2/16: Interdisciplinary Grand Rounds, University of Ghent. “The Potential for Precision Medicine to Improve Value and Decrease Variability – A Case Study in PCI”, Ghent, Belgium 2/4/16: Grand Rounds, “Overview of Patient Reported Outcomes in Cardiology”, Saint Luke’s Mid America Heart Institute, Kansas City, MO 2/19/16: Presentor, “Tailoring Therapy to Risk” Workshop, ACC CV Summit, Las Vegas NV 2/20/16: Presentor, “Using your Data to Reduce Costs and Improve Care”, ACC CV Summit, Las Vegas NV 2/25/16: Grand Rounds, “The Potential for Precision Medicine to Improve Value and Decrease Variability – A Case Study in PCI”, Community Surgical Grand Rounds, Dell Medical School/UT Austin, Austin TX 3/1/16: Plenary Moderator, “The Quantified Self”, Annual QCOR Scientific Sessions, Phoenix, AZ 3/10/16: Grand Rounds, “The Potential for Precision Medicine to Improve Value and Decrease Variability – A Case Study in PCI”, Westchester Medical Center, Westchester NY 3/12/16: Moderator, “Beyond Mortality - Quality of Life in LVAD Patients”, INTERMACS Annual Meeting, Atlanta GA 3/30/16: Grand Rounds, “The Potential for Precision Medicine to Improve Value and Decrease Variability – A Case Study in PCI”, Stony Brook Medical Center, Long Island, NY 4/3/16: Plenary Speaker, “Formal Risk-Benefit Assessment in Guidelines – Often Ignored”, ACC Annual Scientific Sessions, Chicago, IL 4/4/16: Moderator, Young Investigator Award, ACC Annual Scientific Sessions, Chicago, IL 4/14/16: Keynote Speaker, “The Potential for Precision Medicine to Incrase Value and Decrease Variabilty – Where We’ve been and Where We’re Going”, Leadership Alliance for Cardiovascular Care, Kansas City MO 4/18/16: Keynote Speaker, “The Potential for Precision Medicine to Improve Value and Decrease Variability – A Case Study in PCI”, Providence Health System CV Quality Meeting, Seattle WA 4/26/16: Grand Rounds, “The Potential for Precision Medicine to Improve Value and Decrease Variability – A Case Study in PCI”, Sentara Health System, Norfolk VA 5/16/16: Plenary Speaker, The Potential for Precision Medicine to Improve Value and Decrease Variability in Care, International Consortium for Health Outcomes Measurement (ICHOM) Annual Conference, London England 5/19/16: Speaker, Health Outcome and Information Technology, KCALSI Strategic Assessment Committee, Kansas City, MO 6/25/16: Speaker, Entreprneurship as a Means to Sustain and Disseminate Research, AHA Research Summit, San Antonio, TX 8/5/16: Keynote Lecture, The Potential for Precision Medicine to Improve Value and Decrease Variability in Care – A Case Study in PCI, Australia New Zealand Cardiovascular Scientific Sessions, Adelaide, Australia 8/6/16: Speaker, Shared Decision-Making: Engaging the Patient in Treatment, Australia New Zealand Cardiovascular Scientific Sessions, Adelaide, Australia 8/8/16: Keynote Speaker, The Potential for Precision Medicine to Improve Healthcare Value, Australia Transforming Health Steering Committee, Adelaide, Australia 9/16/16: Keynote Speaker, The Potential for Precision Medicine to Improve Value and Decrease Variability in Healthcare, Canadian Rhythm Society National Meeting, Calgary Canada 10/16/16: John R Clark Keynote Address, Opportunities for Precision Medicine to Transform Surgical Practice – A Path Forward, Surgical Outcomes Club, American College of Surgeons, Washington DC 10/22/16:Opening Keynote Lecture, The Use of Precision Medicine to Improve the Value of Healthcare, Canadian Cardiovascular Society Annual Scientific Session, Montreal, Canada 10/23/16:Special Session, Evolving Paradigms of High-Value Healthcare in the US, Canadian Cardiovascular Society Annual Scientific Session, Montreal, Canada 10/28/16: Keynote Speaker, New Stratgies for Defining the Benefits of Thrombolytic Therapy in Acute Ischemic Stroke, Intermountain Health Stroke Conference, Salt Lake City, UT 10/30/16: Discussant, Clincial Trial Design and Interpretation, Transcatheter Cardiovascular Therapeutics Annual Meetign, Washington DC 10/30/16: Presentor, QoL Measures as a Valid Clinical Surrogate and Primary Endpoint in Clincial Tirals: Why the Resistance, Transcatheter Cardiovascular Therapeutics Annual Meetign, Washington DC 11/1/16: Discussant, Late Breaking Clinical Trials, Transcatheter Cardiovascular Therapeutics Annual Meetign, Washington DC 11/1/16: Discussant, Revascularization Decisions and Therapies for the Diabetic Patient, Transcatheter Cardiovascular Therapeutics Annual Meetign, Washington DC 11/1/16: Presentor, When Equipoise Exists: Is Unbiased Informed Consent Possible?, Transcatheter Cardiovascular Therapeutics Annual Meetign, Washington DC 11/15/16: Special Session, Closing the Scientific Gap and What We Need to Know, American Heart Association Scientific Sessions, New Orleans, LA 11/15/16: Special Session, Presentation and Delays in Care for Young Women with AMI, American Heart Association Scientific Sessions, New Orleans, LA 12/1/16: Medicine Grand Rounds, The Role of Precistion Medicine in Improving Patient-Centered Care, University of Missouri – Columbia, Columbia, MO 12/8/16: Medicine Grand Rounds, The Future of Precision Medicine to Improve the Value of Patient-Centered Care, Stanford University, Palo Alto, CA 12/10/16: Keynote Speaker, The Development, Use and Interpretation of Patient-Reported Outcomes, National Center of Cardiovascular Disease, Beijing China 12/14/16: Keynote Speaker, Opportunities to Develop Community Leadership in Healthcare Quality and Outcomes Research, Digital Health Innovation Forum KC, Kansas City, MO 1/12/17: Medicine Grand Rounds, The Role of Precistion Medicine in Improving Patient-Centered Care, University of Utah, Salt Lake City, UT 1/12/17: Moderator, Heart Failure Recovery Symposium, University of Utah, Salt Lake City, UT 1/26/17: Speaker, Team-based Care, ACC CV Leadership Summit, Orlando FL 1/27/17: Speaker, Patient-reported Outcomes, ACC CV Leadership Summit, Orlando FL 2/1/17: Cardiovascular Grand Rounds, Challenges and Opportunities for Delivering Precision Medicine in Clinical Care, Cedars Sinai Medical Center, Los Angeles CA 2/14/17: Medicine Grand Rounds, The Role of Precistion Medicine in Improving Patient-Centered Care: Challenges and Opportunities, University of South Florida, Tampa, FL 2/21/17: Special CV Seminar, Use of Patient-reported Outcomes in Routine Clinical Care, University of Utah, Salt Lake City, UT 3/8/17: Research Grand Rounds, Use of PROs as Endpoints in Clinical Trials, Novartis Pharmaceuticals, Boston, MA 3/27/17: FDA-Duke Collaboratory Grand Rounds, Use of PROs in Clinical Trials, Webinar broadcast from Kansas City MO 4/3/17: Moderator, Implementation Research, AHA Quality of Care and Outcomes Research Conference, Washington DC 4/13/17: Medical Grand Rounds, An Overview of the Use and Application of PROs in Research, Quality Assessment and Clincial Care, University of Washington, Seattle WA 4/14/17: Cardiovascular Grand Rounds, Use of Precision Medicine to Improve Quality and Decrease the Variabilty in Care: PCI Case Study, University of Washington, Seattle WA 5/3/17: Visiting Professor and Grand Rounds, Use of Precision Medicine to Improve Quality and Decrease the Variabilty in Care: PCI Case Study, Wake Forrest University, Winston-Salem, NC 5/31/17: Dean’s Conference, Outcomes Research, Precision Medicine and New Opportunities for UMKC, UMKC, Kansas City, MO 6/15/17: Plenary Speaker, Limitation of Guidelines and the Future of Evidence-based Care, SOSCEP Conference, Sao Paolo, Brazil 6/15/17: Plenary Speaker Fleury Symposium, Evolving Challenges in Cardiovascular Care for the Elderly, SOSCEP Conference, Sao Paolo, Brazil 6/16/17: Plenary Speaker, According to Guidelines, Who should be Revascularized?, SOSCEP Conference, Sao Paolo, Brazil 6/16/17: Plenary Speaker, Quality of Care, Why it will Change Practice, SOSCEP Conference, Sao Paolo, Brazil 9/11/17: Cardiovascular Grand Rounds, Use of Precision Medicine to Improve Quality and Decrease the Variabilty in Care: PCI Case Study, Medstar Washington Hospital, Washington DC 9/18/17: Plenary Speaker, Precision Medicine to Improve the Value of Care in Cardiology, APPROACH meeting, Calgary, CA 9/26/17: Plenary Speaker, More from PROs to PRO-PMs, Physician Consortium for Performance Improvement, Chicago, IL 10/30/17: Discussant, Late-breaking Clinical Trials, Trans-Catheter Therapeutics 2017, Denver, CO 10/30/17: Discussant, Clinical Trial Design and Statistics – From Vasic Interpretation to Advanced Concepts, Trans-Catheter Therapeutics 2017, Denver, CO 10/30/17: Discussant, SCAI Cath Lab Leadership Bootcamp @TCT2017, Trans-Catheter Therapeutics 2017, Denver, CO 10/30/17: Speaker, Cath Lab Economics and Payments: Mastering MACRA, SCAI Cath Lab Leadership Bootcamp @TCT2017, Trans-Catheter Therapeutics 2017, Denver, CO 11/12/17: Speaker, A Precision-based Approach to Risk Benefit Estimation and does it Matter to Patients? American Heart Association Scientific Sessions, Anaheim CA 11/13/17: Moderator, Great Debates in Medical Management, American Heart Association Scientific Sessions, Anaheim CA 12/2/17: Speaker, New Insights from the Guidelines on the Management of Mitral Regurgitation, ACC Asia-Pacific Conference, Shanghai, China 12/3/17: Speaker, A Researcher’s Approach to Publishing Scientific Articles, Rising Stars Seminar, Shanghai, China 12/3/17: Moderator, Challenges in the Management of Valvular Heart Disease, ACC Asia-Pacific Conference, Shanghai, China 1/9/18: Speaker, Cardiovascular Conference, Implementation of Precision Medicine in the Cath Lab, Mills-Peninsula Hospital, San Francisco CA 1/29/18: Speaker, The Prevalance and Conseuqences of Medical Non-Adherence, ACC Webinar Series, Guangzhao China Yüklə 286,42 Kb. Dostları ilə paylaş:
|